Quantitative analysis of injury-induced anterior subcapsular cataract in the mouse: A model of lens epithelial cells proliferation and epithelial-mesenchymal transition

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Xiao, Wei ^a   Chen, Xiaoyun ^a   Li, Weihua ^a   Ye, Shaobi ^a   Wang, Wencong ^a   Luo, Lixia ^a   Liu, Yizhi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CATARACT; CELL PROLIFERATION; DISEASE MODEL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EYE INJURY; INJURIES; LENS; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; CATARACT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EYE INJURIES; LENS, CRYSTALLINE; MICE;

EID: 84954318824     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08362     Document Type: Article

References (27)

1. McCarty, C. A. & Taylor, H. R. Recent developments in vision research: light damage in cataract. Invest Ophthalmol Vis Sci 37, 1720-1723 (1996).
2. Nathu, Z. et al. Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation. Exp Eye Res 88, 323-330 (2009).
3. Shin, E. H., Basson,M. A., Robinson,M. L., McAvoy, J.W. & Lovicu, F. J. Sprouty is a negative regulator of transforming growth factor beta-induced epithelial-tomesenchymal transition and cataract. Mol Med 18, 861-873 (2012).
4. Awasthi, N., Guo, S. & Wagner, B. J. Posterior capsular opacification: a problem reduced but not yet eradicated. Arch. Ophthalmol. 127, 555-562 (2009).
5. Apple, D. J. et al. Posterior capsule opacification. Surv Ophthalmol 37, 73-116 (1992).
6. Hodge, W. G. Posterior capsule opacification after cataract surgery. Ophthalmology 105, 943-944 (1998).
7. Srinivasan, Y., Lovicu, F. J. & Overbeek, P. A. Lens-specific expression of transforming growth factor beta1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest 101, 625-634 (1998).
8. de Iongh, R. U., Wederell, E., Lovicu, F. J. &McAvoy, J.W. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs 179, 43-55 (2005).
9. Wallentin, N., Wickstrom, K. & Lundberg, C. Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 39, 1410-1418 (1998).
10. Meacock, W. R., Spalton, D. J. & Stanford, M. R. Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol 84, 332-336 (2000).
11. Eldred, J. A., Dawes, L. J. & Wormstone, I. M. The lens as a model for fibrotic disease. Philos Trans R Soc Lond B Biol Sci 366, 1301-1319 (2011).
12. Allen, J. B., Davidson, M. G., Nasisse, M. P., Fleisher, L. N. &McGahan, M. C. The lens influences aqueous humor levels of transforming growth factor-beta 2. Graefes Arch Clin Exp Ophthalmol 236, 305-311 (1998).
13. Chen, X. et al. The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. Cell Death Dis 4, e884 (2013).
14. Saika, S. et al. Smad translocation and growth suppression in lens epithelial cells by endogenous TGFbeta2 during wound repair. Exp. Eye Res. 72, 679-686 (2001).
15. Oharazawa, H., Ibaraki, N., Lin, L. R. & Reddy, V. N. The effects of extracellular matrix on cell attachment, proliferation and migration in a human lens epithelial cell line. Exp. Eye Res. 69, 603-610 (1999).
16. Saika, S. et al. Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci 44, 2094-2102 (2003).
17. Martinez, G. & de Iongh, R. U. The lens epithelium in ocular health and disease. Int J Biochem Cell Biol 42, 1945-1963 (2010).
18. Yamamoto, N.,Majima, K. &Marunouchi, T. A study of the proliferating activity in lens epithelium and the identification of tissue-type stem cells. Med Mol Morphol 41, 83-91 (2008).
19. Saika, S. et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am. J. Pathol. 164, 651-663 (2004).
20. Tang, J., Yan, H. & Zhuang, S. Histone deacetylases as targets for treatment of multiple diseases. Clin. Sci. (Lond) 124, 651-662 (2013).
21. Rombouts, K. et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp. Cell Res. 278, 184-197 (2002).
22. Xiao, W. et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. J Cell Mol Med 18, 646-655 (2014).
23. Duan, H., Heckman, C. A. & Boxer, L. M. Histone deacetylase inhibitors downregulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol 25, 1608-1619 (2005).
24. Henderson, C. et al. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem 278, 12579-12589 (2003).
25. Van Beneden, K. et al. Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. Toxicol Appl Pharmacol 271, 276-284 (2013).
26. Conchello, J. A. & Lichtman, J. W. Optical sectioning microscopy. Nat Methods 2, 920-931 (2005).
27. Paddock, S. W. Principles and practices of laser scanning confocal microscopy. Mol Biotechnol 16, 127-149 (2000).